>
Industry
Pharmaceuticals
Topic
Financial Results
People
Find news about people
Organizations
Find news about organizations
Alumni
Find news on alumni of any org
Your Contacts
Find news on your contacts
Sign up for free daily alerts on this feed:
By pressing Sign Up, you agree to our Terms of Use, Privacy Policy, and the LexisNexis Terms & Conditions

Follow

Change Feed

News on Financial Results in Pharmaceuticals

... pot becomes legalized in more places--but they’re also encountering some growing pains. Aurora Cannabis said Monday its revenue rose 260% to $29.7 million Canadian dollars ...
... PR Newswire DelMar Pharmaceuticals, Inc.(NASDAQ: DMPI) ("DelMar" or the "Company"), a biopharmaceutical company focused on the ...
... NovaBay® Pharmaceuticals, Inc. (NYSE American: NBY), a biopharmaceutical company focusing on commercializing prescription Avenova® ...
... Revenue in Q1, 2017 included a $500,000 USD initial license payment from Dechra. ** Product and Services Revenue in Q1 - Q3, 2018 included only ...
... said, "Yesterday, we were very pleased to announce definitive agreements with InvaGen Pharmaceuticals, Inc., USA ("InvaGen"), a subsidiary of Cipla Limited, a leading pharmaceutical company, ...
... as Chief Financial Officer FREMONT,Calif., Nov. 14, 2018 (GLOBE NEWSWIRE) -- Zosano Pharma Corporation (NASDAQ:ZSAN) ("Zosano" or the "Company"), a clinical-stage biopharmaceutical company, today announced ...
... WESTMINSTER, Colo., Nov. 14, 2018 (GLOBE NEWSWIRE) -- ARCA biopharma, Inc. (Nasdaq: ABIO), a biopharmaceutical company applying a precision medicine approach to developing ...
... Financial Officer CHARLOTTESVILLE, Va., Nov. 14, 2018 (GLOBE NEWSWIRE) -- Diffusion Pharmaceuticals Inc. (Nasdaq: DFFN), a cutting-edge biotechnology company developing new treatments for life-threatening medical ...
... pleased to announce very positive results from animal studies in collaboration with Heidelberg Pharma. Antibody drug conjugates (ADCs) are an emerging class of therapeutic agents ...
... Net Proceeds EMERYVILLE, Calif., Nov. 14, 2018 (GLOBE NEWSWIRE) -- Gritstone Oncology, Inc. (Nasdaq: GRTS), a clinical-stage biotechnology company developing the next generation of cancer ...
Subscribe now for full coverage on Financial Results in Pharmaceuticals
Start My Free Trial